Discontinuation report ERFA-AMIKACIN
| Report ID | 243998 |
| Drug Identification Number | 02489147 |
| Brand name | ERFA-AMIKACIN |
| Common or Proper name | ERFA-AMIKACIN |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AMIKACIN |
| Strength(s) | 250MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 2ml |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-11-22 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | No supply available |
| Company comments | Discontinuation of sales |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-11-27 | English | Compare |
| v2 | 2024-11-27 | French | Compare |
Showing 1 to 2 of 2